Blog

Regular posts covering guidance changes, inspection findings, data methodology, and Redica product updates.

Open filters
Search
Tags
Author
Aditi Singhai
Alison Sathe
Anders Vinther
Anne-Caroline Boillot
Barbara W. Unger
Barry Price
Jackie Torfin
Jerry Chapman
Jon Falker
Katie Terry
Khushboo Agrawal
Mark Agostino
Michael de la Torre
Rebecca Stauffer
Redica Systems
Roger Angarita
Sarah Boynton
Scott Sherrill
Tashil Sharma
Subscribe to our Newsletter
Regular posts covering guidance changes, inspection findings, data methodology, and Redica product updates.
Subscribe
Trends

Redica Responds: What are Common Laboratory Inspection Findings?

May 1, 2023
Redica Systems
483
Inspections
laboratory
Quality
Conference Spotlight

A Deep Dive into Cell and Gene Therapy Regulatory Considerations: Part One

April 27, 2023
Jerry Chapman
Cell and Gene
CGT
Quality
Enforcement

Internal Audit Reports: Can the FDA Take a Peek?

April 19, 2023
Jerry Chapman
FDA
GMP
Internal Audits
Pharma
Quality

Audience Q&A: From Data Integrity and Quality Culture Webinar

April 3, 2023
Redica Systems
No items found.
Conference Spotlight

Is Raw FDA Data Skewing Your Analyses?

March 23, 2023
Redica Systems
Drug recalls
GMP
Pharma
Quality
quality systems

On-Demand Webinar: Quality Intelligence: from Information to Knowledge

March 21, 2023
Redica Systems
No items found.

Beyond Data Integrity: Ulrich Köllisch on Building a Culture for Tomorrow’s High-End Data Tools

March 14, 2023
Redica Systems
483
Data Integrity
GMP
Quality
Conference Spotlight

Should ICH Tackle Standard Development for CGT Products?

March 8, 2023
Jerry Chapman
483
GMP
ICH
ISPE Annual Meeting
Pharma

What Are Inferred CFR Codes?

February 24, 2023
Redica Systems
CFR
citations
Dupont
FDA
Form 483

On-Demand Webinar | Comparing Inspection Observations between FDA and Health Canada

February 9, 2023
Redica Systems
No items found.

Does Your Lab Instrumentation Adhere to Data Integrity Requirements?

February 2, 2023
Rebecca Stauffer
analytical instruments
Bob McDowall
Data Ingegrity
Quality
Conference Spotlight

FDA on the Evolution of Biologics Inspections: Part III

January 26, 2023
Jerry Chapman
Biologics
BLAs
FDA
FDA inspection
remote inspection

The “O” in ALCOA

January 17, 2023
Redica Systems
No items found.

How “Inevitable” Data Integrity Issues Cause Havoc: Part II

December 12, 2022
Redica Systems
No items found.
Conference Spotlight

FDA on the Evolution of Biologics Inspections: Part II

December 6, 2022
Jerry Chapman
Biologics
CDER
FDA
FDA Inspections
GMP by the Sea
Conference Spotlight

FDA on the Evolution of Biologics Inspections: Part I

November 28, 2022
Jerry Chapman
Biologics
CBER
ConOps
FDA
FDA Inspections
Trends

Instant Download: Insights on Quality from FDA Leaders

November 8, 2022
Redica Systems
No items found.

Quality Week 2022: A Global Celebration of Quality

November 7, 2022
Rebecca Stauffer
Quality Week

Other Resources

Assessments

Insights on inspections, risk and compliance

Reports

Benchmark industry trends and best practices

Webinars

Hear from industry leaders and Redica experts.